Navigation Links
3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
Date:7/22/2011

SHENYANG, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited second quarter 2011 results after the NASDAQ stock market closes on Monday, August 15, 2011 at 8:00pm (US Eastern).

Following the earnings announcement, 3SBio's senior management will host a conference call on Tuesday, August 16, 2011 at 5:00am (US Pacific) / 8:00am (US Eastern) / 8:00pm (Beijing) to discuss its unaudited second quarter 2011 results and recent business activity. The conference call may be accessed using the dial-in numbers below:Conference ID: 83204042Local dial-in:China landline: 800-819-0121China mobile: 400-620-8038Hong Kong : 852-2475-0994United States: 718-354-1231 International toll-free dial-in:Hong Kong:  800930346United States:  1-866-519-4004United Kingdom:  080-8234-6646International toll dial-in: 65 6723 9381Replay- Conference ID: 83204042A telephone replay will be available two hours after the call until August 23, 2011 at:

International:  61-2-8235-5000United States: 1-866-214-5335WebcastA live webcast of the conference will be available on the investor relations section of 3SBio's website at www.3sbio.com and at http://tinyurl.com/3sbio2Q11.

A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 700 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.

Investor ContactsBo TanChief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820ir@3SBio.comTom FolinsbeeDirector of Investor Relations3SBio Inc. Tel: + 852 8191-6991ir@3SBio.com
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
2. 3SBio Announces Conversion of Isotechnika Debenture
3. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
4. 3SBio Announces Partial Conversion of Isotechnika Debenture
5. 3SBio Announces Investor Conference Schedule
6. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
7. 3SBio Inc. Announces Results of Annual General Meeting
8. WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
9. MSA Schedules Second Quarter Earnings Webcast
10. TPI Schedules Test Runs at Jiangchuan Macrolide Facility by End of July
11. Cepheid Schedules 2011 Second Quarter Financial Results Announcement and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Inc. ("Hill-Rom") (NYSE: HRC), today announced financial results for ... updated its financial outlook for fiscal 2017. ... quarter, Hill-Rom reported earnings of $0.09 per diluted share ... period. These results reflect after-tax special items, including a ... the non-cash write-down of assets associated with the planned ...
(Date:7/28/2017)... FLINT, Mich. , July 28, 2017 EnvoyHealth, ... (CMT) to pilot a program for CleverCap LITE, a ... CMT strives to deliver innovative health technology solutions ... adherence. CleverCap LITE ... The compact, high-tech bottle cover: ...
(Date:7/27/2017)... Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results ... reported second quarter net sales of $1.954 billion, an ... an increase of 2.1% on a constant currency basis.  ... LDR Holding Corporation acquisition, second quarter 2017 revenues decreased ... on a constant currency basis. ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... 2017 , ... Conventus, New Jersey’s premier professional liability insurer ... new educational series of webinars and podcasts to guide medical practices on understanding ... The first two episodes of the series, entitled “Pain Management and Opioids: New ...
(Date:7/27/2017)... Wayne, NJ (PRWEB) , ... July 27, 2017 ... ... C. Breiterman is now inviting new patients with sleep apnea in ... referral. Dental sleep medicine helps patients treat their sleep apnea with the use ...
(Date:7/27/2017)... , ... July 27, 2017 , ... For bicycling enthusiasts ... does challenge. The 24-hour race takes place against a backdrop of tree-lined hills at ... to run from July 28-30, Rad am Ring consists of some 73 curves, stretching ...
(Date:7/27/2017)... CA (PRWEB) , ... July 27, 2017 , ... ... the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution to its ... accelerated diagnostics and sleep care management. The speed and functionality of scoring in ...
(Date:7/27/2017)... ... July 27, 2017 , ... GAFFEY ... internal promotion of Elrene Clinkscales to Vice President of Revenue Cycle Business Services ... reporting to Derek Morkel, chief executive officer (CEO). , Elrene has been with ...
Breaking Medicine News(10 mins):